5 Key Takeaways

• 1

  The Glaucoma Trials Tracker provides a comprehensive listing of active interventional clinical trials related to glaucoma.

• 2

  Several trials are evaluating new treatments, including brimonidine tartrate and topical insulin, for managing glaucoma.

• 3

  Phase 2 and Phase 3 trials are assessing the safety and efficacy of various glaucoma therapies, including NT-501 encapsulated cell therapy.

• 4

  The trials involve diverse approaches, such as drug implants, eye drops, and surgical techniques for intraocular pressure reduction.

• 5

  Enrollment numbers for these trials range from 20 to over 600 participants, indicating a significant interest in glaucoma research.